Documentos relacionados

1. The safety of long-term use of inhaled corticosteroids in patients with asthma: A systematic review and meta-analysis.
2. Identification of cough-variant asthma phenotypes based on clinical and pathophysiologic data.
3. Benralizumab affects NK cell maturation and proliferation in severe asthmatic patients.
4. Airway autoimmunity, asthma exacerbations, and response to biologics.
5. "Patient remodeling" as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend.
6. Cost-effectiveness and resource use analysis of patients with asthma before and after treatment with mepolizumab in a real-life setting.
7. Real-life experience after 3 months with tezepelumab before marketing approval.
8. Adverse events of anti-IL-5 drugs in patients with eosinophilic asthma: a meta-analysis of randomized controlled trials and real-world evidence-based assessments.
9. Remission in asthma.
10. Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation.